Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice

Immunology Letters

Volumn 49, Issue 3, 1996, Pages 143-147

  Hasko G ^a   Szabo C ^a,b   Merkel, K ^a   Bencsics, A ^a   Zingarelli, B ^b   Kvetan, V ^c   Vizi, E S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Bromocryptine; Dopamine D1 receptors; Dopamine D2 receptors; Lipopolysaccharide induced tumor necrosis factor ; SCH 23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; QUINPIROLE; SULPIRIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029968916     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-2478(96)02494-7     Document Type: Article

References (30)

1. Santambrogio, L., Lipartiti, M., Bruni, A. and Dal Toso, R. (1993) J. Neuroimmunol. 45, 113.
2. Ricci, A., Vega, J.A. and Amenta, F. (1994) J. Neuroimmunol. 50, 133.
3. Le Fur, G., Phan, T. and Uzan, A. (1980) Life Sci. 26, 1139.
4. Sternberg, E.M., Trial, J. and Parker, C.W. (1986) J. Immunol. 137, 276.
5. Sternberg, E.M., Wedner, H.J., Leung, M.K. and Parker, C.W. (1987) J. Immunol. 138, 4360.
6. Pierpaoli, W. and Maestroni, G.J.M. (1978) Immunology 34, 419.
7. Pierpaoli, W. and Maestroni, G.J.M. (1978) J. Immunol. 120, 1600.
8. Kouassi, E., Boukhris, W., Descotes, J., Zukervar, P., Li, Y.S. and Revillard, J.P. (1987) Immunopharm. Immunotechnol. 248, 477.
9. Boukhris, W., Kouassi, E., Descotes, J., Cordier, G. and Revillard, J.P. (1987) J. Clin. Lab. Immunol. 23, 185.
10. Nistico, G., Caroleo, M.C., Arbitrio, M. and Pulvirenti, L. (1994) Ann. NY Acad. Sci. 741, 316.
11. Nagy, E., Berczi, I., Wren, G.E., Asa, S.L. and Kovacs, K. (1983) Immunopharmacology 6, 231.
12. Youdim, M.B., Lavie, L. and Riederer, P. (1994) Ann. NY Acad. Sci. 738, 64.
13. Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y. and Hirsch, E.C. (1994) Neurosci. Lett. 172, 151.
14. Szabó, C. (1995) New Horizons 3, 2.
15. Glauser, M.P., Zanetti, G., Baumgartner J.D. and Cohen, J. (1991) Lancet 338, 732.
16. Fong, Y. and Lowry, S.F. (1990) Clin. Immunol. Immunopathol. 55, 157.
17. Durum, S.K. and Oppenheim, J.J. (1989) in: Fundamental Immunology (W.E. Paul, Ed.), pp. 639-661. Raven Press, New York.
18. Tracey, K.J., Beutler, B., Lowry, S.F., Merryweather, J., Wolpe, S., Milsark, I.W., Hariri, R.J., Fahey, T.J. III, Zentella, A., Albert, J.D., Shires, G.T. and Cerami, A. (1986) Science 234, 470.
19. Dinarello, C.A. (1992) European Cytokine Network 3, 7.
20. Brosnan, C.F., Selmaj, K. and Raine, C.S. (1988) J. Neuroimmunol. 18, 87.
21. Brennan, F.M., Maini, R.N. and Feldmann, M. (1992) Br. J. Rheumatol. 31, 293.
22. Hasko, G., Elenkov, I.J., Kvetan, V. and Vizi, E.S. (1995) J. Endocrinol. 144, 457.
23. Elenkov, I.J., Haskó, G., Kovács, K.J. and Vizi, E.S. (1995) J. Neuroimmunol. 61, 123.
24. Severn, A., Rapson, N.T. Hunter, C. and Liew, F.Y. (1992) J. Immunol. 148, 3441.
25. Dunn, A.J. (1992) J. Pharmacol. Exp. Ther. 261, 964.
26. Ader, R., Felten, D. and Cohen, N. (1990) Ann. Rev. Pharmacol. Toxicol. 30, 561.
27. Bernton, E.W., Meltzer, M.S. and Holaday, J.W. (1988) Science 239, 401.
28. Hiestand, P.C., Mekler, P., Nordmann, R., Grieder, A. and Permmongkol, C. (1986) Proc. Natl. Acad. Sci. USA 83, 2599.
29. Thiemermann, C., Wu, C.C., Szabó, Cs., Perretti, M. and Vane, J.R. (1993) Br. J. Pharmacol. 110, 177.
30. Green, S.J., Nacy, C.A., Schreiber, R.D., Granger, D.L., Crawford, R.M., Meltzer, M.S. and Fortier, A.H. (1993) Infect. Immun. 61, 689.